Cargando…
Histoplasmosis in Patients With Cell-Mediated Immunodeficiency: Human Immunodeficiency Virus Infection, Organ Transplantation, and Tumor Necrosis Factor-α Inhibition
Background. Histoplasmosis causes severe disease in patients with defects of cell-mediated immunity. It is not known whether outcomes vary related to the type of immunodeficiency or class of antifungal treatment. Methods. We reviewed cases of active histoplasmosis that occurred at Vanderbilt Univers...
Autores principales: | Luckett, Keith, Dummer, J. Stephen, Miller, Geraldine, Hester, Sydney, Thomas, Lora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438880/ https://www.ncbi.nlm.nih.gov/pubmed/26034750 http://dx.doi.org/10.1093/ofid/ofu116 |
Ejemplares similares
-
Single High Dose of Liposomal Amphotericin B in Human Immunodeficiency Virus/AIDS-Related Disseminated Histoplasmosis: A Randomized Trial
por: Pasqualotto, Alessandro C, et al.
Publicado: (2023) -
Histoplasmosis as a presentation of human immunodeficiency virus infection.
por: Carey, F. M., et al.
Publicado: (2002) -
Lung Function in Women With and Without Human Immunodeficiency Virus
por: Wang, Richard J, et al.
Publicado: (2022) -
Hemophagocytic Lymphohistiocytosis Secondary to Human Immunodeficiency Virus-Associated Histoplasmosis
por: Castelli, Anthony A., et al.
Publicado: (2015) -
Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium Between 2013 and 2019
por: Mortier, Virginie, et al.
Publicado: (2022)